SEM · As filed with the SEC
Select Medical Holdings income statement, by quarter
The statement as Select Medical Holdings presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Condensed Consolidated Statements of Operations (unaudited) · USD thousands, except per-share amounts
| USD thousands, except per-share amounts | Q1 2026 3 months ended Mar 31, 2026 | Q4 2025† 3 months ended Dec 31, 2025 | Q3 2025 3 months ended Sep 30, 2025 | Q2 2025 3 months ended Jun 30, 2025 |
|---|---|---|---|---|
| Revenue | 1,421,476 | 1,396,634† | 1,363,445 | 1,339,579 |
| Costs and expenses: | ||||
| Cost of services, exclusive of depreciation and amortization | 1,246,008 | 1,250,800† | 1,215,995 | 1,184,129 |
| General and administrative | 39,384 | 45,693† | 40,050 | 35,663 |
| Depreciation and amortization | — | 36,205† | 34,442 | 34,848 |
| Depreciation and amortization | 37,666 | — | — | — |
| Total costs and expenses | 1,323,058 | 1,332,698† | 1,290,487 | 1,254,640 |
| Other operating income | — | 0† | 0 | 1,592 |
| Income from operations | 98,418 | 63,936† | 72,958 | 86,531 |
| Other income and expense: | ||||
| Loss on early retirement of debt | — | 0† | 0 | — |
| Equity in earnings of unconsolidated subsidiaries | — | 15,399† | 12,992 | 13,618 |
| Equity in earnings of unconsolidated subsidiaries | 12,011 | — | — | — |
| Interest expense | (28,336) | (28,871)† | (30,021) | (29,978) |
| Income before income taxes | 82,093 | 50,464† | 55,929 | 70,171 |
| Income tax expense | 18,318 | 12,722† | 11,749 | 12,292 |
| Income from continuing operations, net of tax | — | 37,742† | 44,180 | 57,879 |
| Income from discontinued business | — | 0† | 0 | 0 |
| Income tax expense from discontinued business | — | 0† | 0 | 0 |
| Income from discontinued operations, net of tax | — | 0† | 0 | 0 |
| Net income | 63,775 | 37,742† | 44,180 | 57,879 |
| Less: Net income attributable to non-controlling interests | 19,780 | 17,568† | 15,387 | 17,308 |
| Net income attributable to Select Medical Holdings Corporation | 43,995 | 20,174† | 28,793 | 40,571 |
| Income from continuing operations, net of tax | — | 20,174† | 28,793 | 40,571 |
| Income from discontinued operations, net of tax | — | 0† | 0 | 0 |
| Earnings per common share (Note 11): | ||||
| Continuing operations - basic (in dollars per share) | — | — | 0.23 | 0.32 |
| Continuing operations - diluted (in dollars per share) | — | — | 0.23 | 0.32 |
| Discontinued operations - basic (in dollars per share) | — | — | 0.00 | 0.00 |
| Discontinued operations - diluted (in dollars per share) | — | — | 0.00 | 0.00 |
| Basic (in dollars per share) | 0.35 | — | 0.23 | 0.32 |
| Diluted (in dollars per share) | 0.35 | — | 0.23 | 0.32 |
† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.